Fixed-dose combination therapy for Parkinson's disease with a spotlight on entacapone in the past 20 years
Parkinson's disease (PD) is a progressive, chronic neurodegenerative disorder. The main neuropathological cause of the disease is the death of dopaminergic neurons in the substantia nigra. Unfortunately, there is no curative treatment yet. The gold-standard of the treatment is levodopa (LD). Du...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2020
|
| Sorozat: | EXPERT OPINION ON PHARMACOTHERAPY
21 No. 18 |
| doi: | 10.1080/14656566.2020.1806237 |
| mtmt: | 31543815 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/19692 |